Adaptive Biotechnologies Corp — Director's Dealing 2020

Jan 10, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-01-08

Reporting Person: Taylor Stacy L (SVP and General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1300	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.55	2028-04-24	Common Stock (52662)		Direct
Stock Option (Right to Buy)	$7.80	2029-04-23	Common Stock (50000)		Direct

Footnotes

F1: The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F2: The options will vest with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.